Fresenius Medical Care Appoints Dr. Carla Kriwet as CEO

Fresenius Medical Care has appointed Dr. Carla Kriwet as its new CEO, effective Jan 1, 2023. She will succeed Rice Powell, who has led the company for 10 years. Dr. Kriwet will also become a member of the Fresenius board.
 
Dr. Kriwet most recently led BSH Hausgeräte GmbH as president and CEO. From 2013 to 2020 she worked at Philips, where she eventually headed the company’s Connected Care division.
 
“After 25 years with this company, and a full decade as CEO, I look back with a lot of gratitude and pride at what we achieved during this time,” Powell told the press. “Our products and services are more important than ever to our patients, and a fundamental part of their lives. As the world’s only provider of the full range of innovative therapies and products for people with renal diseases, we have outstanding prerequisites for our continued success. I want to thank all my colleagues—on the Management Board, the management team, and everyone in all our facilities worldwide—for their untiring efforts and support over the years. I’m very happy to know that our company will be in good hands in the future.”
 
Stephan Sturm, Chairman of the Fresenius Medical Care Management AG Supervisory Board and CEO of Fresenius, added: “I am very thankful to Rice Powell for his highly dedicated service over many years, and for his important contribution to our success. He played a key role in shaping Fresenius Medical Care, initiated future-looking developments and set in motion the necessary transformation of the company. On behalf of the entire Supervisory Board and the Management Board of Fresenius, I wish Rice all the very best for the next stage of his life, with more time for his family and hobbies. At the same time, I am very much looking forward to working with Dr. Carla Kriwet. I have come to know her as a highly skilled and bold manager with a lot of experience in the healthcare industry, clear ideas and a lot of empathy. People’s health and well-being are very close to her heart, and something she has worked for over the years in different organizations and constellations. I’m certain that working closely with Helen Giza, and together with the entire management team, she will successfully shape the transformation now underway and manage the challenges, not least those created by the pandemic, embrace with enthusiasm the numerous growth opportunities before us, and lead Fresenius Medical Care to continued success.”
 
Dr. Kriwet said: “I am very much looking forward to taking on this new position and working together with my new colleagues. I fully identify with the vision of making the lives of the patients who have put their trust in us a little more worth living every day. And I’m convinced that bringing ever better medicine to ever more people goes hand in hand with economic success. Early in my professional development, I found my way into the healthcare business and have remained very closely connected to it ever since. Fresenius Medical Care is a globally active, leading and unique company that still has tremendous potential. I want to do my part to leverage this potential for the benefit of patients and employees, and in doing so also add shareholder value.”